Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use

BACKGROUND: Dementia networks in Germany constitute a specialised setting for integrated dementia care and have shown benefits on relevant outcomes, including those of drug treatment. National guidelines recommend treatment with acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Health Serv Res
Main Authors: Wübbeler, Markus, Wucherer, Diana, Hertel, Johannes, Michalowsky, Bernhard, Heinrich, Steffen, Meyer, Saskia, Schaefer-Walkmann, Susanne, Hoffmann, Wolfgang, Thyrian, Jochen René
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4460966/
https://ncbi.nlm.nih.gov/pubmed/25998147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-015-0855-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados